Clinical research backing SAINT®
Explore the peer-reviewed research, clinical trials, and real-world data that demonstrate SAINT’s impact on treatment-resistant depression.
TRD
Efficacy
A randomized controlled trial confirming efficacy, and an EEG study providing insight into mechanism of action and a potentially predictive biomarker of efficacy
World Psychiatry | Volume 25, Issue 1, Pages 105-116
MDD
Efficacy
High-dose spaced theta-burst TMS as a rapid-acting antidepressant in highly refractory depression
Brain | Volume 141, Issue 3, Page e18
MDD
Other
Transcranial Magnetic Stimulation Parameter Space: Wide Open for Exploration
Biological Psychiatry | Volume 87, Issue 5, Pages 384-385
MDD
Efficacy
Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression
American Journal of Psychiatry | Volume 177, Issue 8
MDD
Efficacy
Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial
American Journal of Psychiatry | Volume 179, Issue 2
MDD
Neuroimaging
Targeted neurostimulation reverses a spatiotemporal biomarker of treatment-resistant depression
PNAS | Volume 120, Number 21
MDD
Neuroimaging
Network effects of Stanford Neuromodulation Therapy (SNT) in treatment-resistant major depressive disorder: a randomized, controlled trial
Nature Translational Psychiatry | 13, 240
MDD
Other
An Avenue for Optimization of Theta Burst Stimulation Protocols? Comments on the FOUR-D Randomized Noninferiority Clinical Trial
American Journal of Psychiatry | Volume 181, Number 1
MDD
Continuation
12 Months Sustained Remission from Depression using Personalized Continuation Therapy with SAINT®
Magnus Medical
MDD
Durability
Sustained Efficacy of Stanford Neuromodulation Therapy (SNT) in Open-Label Repeated Treatment
American Journal of Psychiatry | Volume 181, Number 1
